Literature DB >> 10505206

CA 15-3 and related mucins as circulating markers in breast cancer.

M J Duffy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10505206     DOI： 10.1177/000456329903600503

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN： 0004-5632            Impact factor:   2.057


× No keyword cloud information.
  20 in total

1.  The expression and clinical significance of serum miR-205 for breast cancer and its role in detection of human cancers.

Authors:  Hui Zhang; Baowei Li; Hebao Zhao; Jin Chang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  The clinical significance of serum soluble Fas and p53 protein in breast cancer patients: comparison with serum CA 15-3.

Authors:  Taha I Hewala; Nadia A Abd El-Monaim; Medhat Anwar; Samia A Ebied
Journal:  Pathol Oncol Res       Date:  2012-03-17       Impact factor: 3.201

3.  Analysis of Isocitrate Dehydrogenase -2 (IDH-2) Activity in Human Serum as a Biomarker in Chemotherapy Patients of Breast Carcinoma: A Case-Control Study.

Authors:  Roshni Gavel; S P Mishra; Seema Khanna; Rahul Khanna; Agni Gautam Shah
Journal:  J Clin Diagn Res       Date:  2017-05-01

4.  Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers.

Authors:  Eui Jin Suh; Mohammad Humayun Kabir; Un Beom Kang; Jong Won Lee; Jonghan Yu; Dong Young Noh; Cheolju Lee
Journal:  Exp Mol Med       Date:  2012-01-31       Impact factor: 8.718

5.  MicroRNA-143 is downregulated in breast cancer and regulates DNA methyltransferases 3A in breast cancer cells.

Authors:  Enders K O Ng; Rufina Li; Vivian Y Shin; Jennifer M Siu; Edmond S K Ma; Ava Kwong
Journal:  Tumour Biol       Date:  2013-11-13

6.  Evidence of porcine and human endothelium activation by cancer-associated carbohydrates expressed on glycoproteins and tumour cells.

Authors:  Olga V Glinskii; James R Turk; Kenneth J Pienta; Virginia H Huxley; Vladislav V Glinsky
Journal:  J Physiol       Date:  2004-01-01       Impact factor: 5.182

7.  Correlation study of Carcino Embryonic Antigen & Cancer Antigen 15.3 in pretreated female breast cancer patients.

Authors:  K Thriveni; Lakshmi Krishnamoorthy; Girija Ramaswamy
Journal:  Indian J Clin Biochem       Date:  2007-03

8.  Profiling protein thiol oxidation in tumor cells using sulfenic acid-specific antibodies.

Authors:  Young Ho Seo; Kate S Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-10       Impact factor: 11.205

9.  Plasma Mucin-1 (CA15-3) Levels in Autosomal Dominant Tubulointerstitial Kidney Disease due to MUC1 Mutations.

Authors:  Petr Vylet'al; Kendrah Kidd; Hannah C Ainsworth; Drahomíra Springer; Alena Vrbacká; Anna Přistoupilová; Rebecca P Hughey; Seth L Alper; Niall Lennon; Steven Harrison; Maegan Harden; Victoria Robins; Abbigail Taylor; Lauren Martin; Katrice Howard; Ibrahim Bitar; Carl D Langefeld; Veronika Barešová; Hana Hartmannová; Kateřina Hodaňová; Tomáš Zima; Martina Živná; Stanislav Kmoch; Anthony J Bleyer
Journal:  Am J Nephrol       Date:  2021-06-07       Impact factor: 3.754

10.  Circulating microRNAs as specific biomarkers for breast cancer detection.

Authors:  Enders K O Ng; Rufina Li; Vivian Y Shin; Hong Chuan Jin; Candy P H Leung; Edmond S K Ma; Roberta Pang; Daniel Chua; Kent-Man Chu; W L Law; Simon Y K Law; Ronnie T P Poon; Ava Kwong
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.